Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001144204-16-132258
Filing Date
2016-11-08
Accepted
2016-11-08 08:06:02
Documents
3
Effectiveness Date
2016-11-08

Document Format Files

Seq Description Document Type Size
1 S-8 v452320_s8.htm S-8 54125
2 EXHIBIT 5.1 v452320_ex5-1.htm EX-5.1 6176
3 EXHIBIT 23.1 v452320_ex23-1.htm EX-23.1 2178
  Complete submission text file 0001144204-16-132258.txt   63558
Mailing Address 675 ARAPEEN DRIVE, SUITE 202 SALT LAKE CITY X1 84108
Business Address 675 ARAPEEN DRIVE, SUITE 202 SALT LAKE CITY X1 84108 801 994 7383
Lipocine Inc. (Filer) CIK: 0001535955 (see all company filings)

EIN.: 990370688 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-214492 | Film No.: 161980014
SIC: 2834 Pharmaceutical Preparations